{"transactions":[{"id":3660712,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2019-02-14T02:40:08.000Z","date":"2019-02-12","kind":"tax_withholding","acquired":false,"shares":4580,"price":88.88,"value":407070.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock automatically forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU and rTSRU awards."}],"balance_after":17547,"source":{"system":"sec-edgar","filing":"0001177648-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764819000017/edgar.xml","form_type":"4"}},{"id":3660711,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2019-02-14T02:40:08.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Enanta common stock issued under a relative total stockholder return unit (\"rTSRU\") award granted to the reporting person on January 4, 2017 that was subject to performance-vesting restrictions based on the relative total stockholder return of Enanta's common stock in relation to the total stockholder return of the component companies in the Nasdaq Biotech Index over a two-year period. The performance level was determined by the Compensation Committee of Enanta's Board of Directors and the rTSRU settled with the issuance of the shares of Enanta common stock on February 12, 2019."}],"balance_after":22127,"source":{"system":"sec-edgar","filing":"0001177648-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764819000017/edgar.xml","form_type":"4"}},{"id":3660710,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2019-02-14T02:40:08.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Enanta common stock issued under a performance share unit (\"PSU\") award granted on January 4, 2017 that vested as a result of the achievement of a clinical development milestone in calendar 2018 as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2019."}],"balance_after":12127,"source":{"system":"sec-edgar","filing":"0001177648-19-000017","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764819000017/edgar.xml","form_type":"4"}},{"id":3743925,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-04T22:42:25.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":58000,"derivative":{"exercise_price":32.27,"expiration_date":"2024-01-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001177648-18-000051","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000051/edgar.xml","form_type":"4"}},{"id":3743924,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-12-04T22:42:25.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":2000,"price":32.27,"value":64540.0,"ownership":{"direct":true},"balance_after":8127,"source":{"system":"sec-edgar","filing":"0001177648-18-000051","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000051/edgar.xml","form_type":"4"}},{"id":3756825,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2018-11-21T01:22:14.000Z","date":"2018-11-16","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 16, 2018)."}],"balance_after":18000,"derivative":{"exercise_price":81.2,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001177648-18-000048","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000048/edgar.xml","form_type":"4"}},{"id":3801731,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":60000,"derivative":{"exercise_price":32.27,"expiration_date":"2024-01-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801730,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to this option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":19.98,"expiration_date":"2023-10-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801729,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":604,"price":85.2995,"value":51520.898,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $84.915 to $85.67, inclusive."}],"balance_after":6127,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801728,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":14677,"price":84.0167,"value":1233113.1059,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $83.77 to $84.73, inclusive."}],"balance_after":6731,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801727,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":6219,"price":83.4744,"value":519127.2936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $82.77 to $83.76, inclusive."}],"balance_after":21408,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801726,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":3500,"price":82.0406,"value":287142.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in August 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $81.84 to $82.21, inclusive."}],"balance_after":27627,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801725,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":10000,"price":32.27,"value":322700.0,"ownership":{"direct":true},"balance_after":31127,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801724,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-10-02T20:22:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":15000,"price":19.98,"value":299700.0,"ownership":{"direct":true},"balance_after":21127,"source":{"system":"sec-edgar","filing":"0001177648-18-000038","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000038/edgar.xml","form_type":"4"}},{"id":3801723,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2018-10-02T20:21:40.000Z","date":"2014-01-30","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amendment is being filed to correct the original Form 4 filing by amending the conversion or exercise price of the derivative security reported in column 2 from \"$32.43\" to \"$32.27\". This amendment corrects an administrative error."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option will vest on the first anniversary of January 30, 2014 (the \"Commencement Date\"), and the remaining shares will vest in twelve (12) successive and equal quarterly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Commencement Date."}],"balance_after":70000,"derivative":{"exercise_price":32.27,"expiration_date":"2024-01-30","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001177648-18-000037","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000037/edgar.xml","form_type":"4/A","original_submission_date":"2014-02-03"}},{"id":4063080,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-02-13T23:26:57.000Z","date":"2018-02-12","kind":"tax_withholding","acquired":false,"shares":2065,"price":76.845,"value":158684.925,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock automatically forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU and rTSRU awards."}],"balance_after":6127,"source":{"system":"sec-edgar","filing":"0001177648-18-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000003/edgar.xml","form_type":"4"}},{"id":4063079,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-02-13T23:26:57.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":4822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Enanta common stock issued under a relative total stockholder return unit (\"rTSRU\") award granted to the reporting person on December 21, 2015 that was subject to performance-vesting restrictions based on the relative total stockholder return of Enanta's common stock in relation to the total stockholder return of the component companies in the Nasdaq Biotech Index over a two-year period. The performance level was determined by the Compensation Committee of Enanta's Board of Directors and the rTSRU settled with the issuance of the shares of Enanta common stock on February 12, 2018."}],"balance_after":8192,"source":{"system":"sec-edgar","filing":"0001177648-18-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000003/edgar.xml","form_type":"4"}},{"id":4063078,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2018-02-13T23:26:57.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Enanta common stock issued under a performance share unit (\"PSU\") award granted on December 21, 2015 that vested as a result of the achievement of a clinical development milestone in calendar 2018 as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2018."}],"balance_after":3370,"source":{"system":"sec-edgar","filing":"0001177648-18-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764818000003/edgar.xml","form_type":"4"}},{"id":4154522,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-22T00:58:48.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":21500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 17, 2017)."}],"balance_after":21500,"derivative":{"exercise_price":48.52,"expiration_date":"2027-11-17","underlying":"Common Stock","underlying_shares":21500},"source":{"system":"sec-edgar","filing":"0001177648-17-000041","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764817000041/edgar.xml","form_type":"4"}},{"id":4445936,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2017-02-15T22:45:36.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":830,"price":29.815,"value":24746.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock forfeited by the reporting person to cover withholding taxes due as a result of settlement of the PSU award."}],"balance_after":1370,"source":{"system":"sec-edgar","filing":"0001177648-17-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764817000008/edgar.xml","form_type":"4"}},{"id":4445935,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Common Stock","published_at":"2017-02-15T22:45:36.000Z","date":"2017-02-13","kind":"grant","acquired":true,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock issued upon vesting of a performance share unit (\"PSU\") award granted on February 20, 2015 as a result of the achievement of a clinical development milestone in 2016 and the settlement and issuance of those shares of common stock on Febuary 13, 2017."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001177648-17-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764817000008/edgar.xml","form_type":"4"}},{"id":4545273,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-22T23:57:37.000Z","date":"2015-11-20","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2015)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This Form 4 is being amended to correct the original Form 4 filing by amending the expiration date of the granted stock option from \"11/20/2014\" to \"11/20/2025\". This amendment corrects an administrative error."}],"balance_after":25500,"derivative":{"exercise_price":31.42,"expiration_date":"2025-11-20","underlying":"Common Stock","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001177648-16-000027","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764816000027/edgar.xml","form_type":"4/A","original_submission_date":"2015-11-24"}},{"id":4545272,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-22T23:45:23.000Z","date":"2014-11-20","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 20, 2014)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This Form 4 is being amended to correct the original Form 4 filing by amending the expiration date of the granted stock option from \"11/20/2014\" to \"11/20/2024\". This amendment corrects an administrative error."}],"balance_after":27500,"derivative":{"exercise_price":44,"expiration_date":"2024-11-20","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001177648-16-000022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764816000022/edgar.xml","form_type":"4/A","original_submission_date":"2014-11-21"}},{"id":4545271,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Restricted Stock Units","published_at":"2016-11-22T23:42:15.000Z","date":"2016-11-18","kind":"grant","acquired":true,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into shares of common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Such restricted stock units will vest as to one half the shares on the third anniversary of the date of award (November 18, 2019) and the remainder on the fourth anniversary of the date of award (November 18, 2020). The restricted stock unit shares that vest will be issued on the first December 15 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements."}],"balance_after":10500,"derivative":{"underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0001177648-16-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764816000020/edgar.xml","form_type":"4"}},{"id":4545270,"issuer":{"id":5673,"kind":"organization","name":"ENANTA PHARMACEUTICALS INC"},"owners":[{"id":160325,"kind":"person","name":"Ocain Tim","position":1,"cik":"0001599020","reported_name":"Ocain Tim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-22T23:42:15.000Z","date":"2016-11-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016)."}],"balance_after":25000,"derivative":{"exercise_price":30,"expiration_date":"2026-11-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001177648-16-000020","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177648/000117764816000020/edgar.xml","form_type":"4"}}]}